ARRHYTHMOGENIC CARDIOMYOPATHY
Clinical trials for ARRHYTHMOGENIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental antibody IC14 tested in rare heart condition
Disease control CompletedThis early-phase trial tested IC14 (atibuclimab), an antibody that targets inflammation, in one person with arrhythmogenic cardiomyopathy (ACM), a rare heart muscle disease that can cause dangerous heart rhythms. The study measured safety, blood markers of inflammation, and heart…
Matched conditions: ARRHYTHMOGENIC CARDIOMYOPATHY
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart condition costs under the microscope in massive hospital study
Knowledge-focused CompletedThis study collected information from over 15,000 people hospitalized with cardiomyopathy, a heart muscle disease. Researchers looked at how much these hospital stays cost and what the money was spent on. The goal was to understand the real-world financial impact and help manage …
Matched conditions: ARRHYTHMOGENIC CARDIOMYOPATHY
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Pilot study probes safe exercise limits for rare heart condition
Knowledge-focused CompletedThis completed pilot study looked at how moderate exercise affects heart function and dangerous heart rhythms in 20 adults with arrhythmogenic cardiomyopathy (ACM). Participants did different types of exercise while doctors measured heart pressures and electrical activity. The go…
Matched conditions: ARRHYTHMOGENIC CARDIOMYOPATHY
Phase: NA • Sponsor: Technical University of Munich • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC